Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-06 Sale | 2025-01-07 9:27 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 45,167 | $19.77 | $893,095 | 455,433 (Direct) | View |
| 2024-03-06 Sale | 2024-03-08 5:54 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 40,000 | $35.19 | $1,407,600 | 400,600 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 5:16 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 16,104 | $35.27 | $567,910 | 440,600 (Direct) | View |
| 2023-06-27 Sale | 2023-06-29 6:41 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 15,000 | $36.2 | $543,000 | 381,704 (Direct) | View |
| 2022-12-29 Sale | 2022-12-30 5:12 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 30,625 | $40 | $1,225,000 | 336,704 (Direct) | View |
| 2022-01-05 Sale | 2022-01-06 8:58 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 40,000 | $61.7 | $2,467,941 | 464,005 (Direct) | View |
| 2021-01-11 Sale | 2021-01-12 6:06 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 13,038 | $81.02 | $1,056,310 | 444,005 (Direct) | View |
| 2021-01-06 Sale | 2021-01-07 6:08 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 30,625 | $72.44 | $2,218,477 | 457,043 (Direct) | View |
| 2020-11-09 Sale | 2020-11-12 5:49 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 43,505 | $69.37 | $3,018,071 | 427,668 (Direct) | View |
| 2020-10-20 Sale | 2020-10-22 6:02 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 29,166 | $54.04 | $1,576,131 | 471,173 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-04 Option Award | 2025-01-07 9:27 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 100,000 | $0 | 455,433 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 5:16 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 75,000 | $0 | 440,600 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 7:14 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 60,000 | $0 | 396,704 (Direct) | View |
| 2022-06-15 Ownership | 2022-09-30 5:32 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 96,676 | $0 | 367,329 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-04 9:25 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 60,000 | $0 | 504,005 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-05 6:20 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 60,000 | $0 | 487,668 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-12 5:49 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 43,505 | $14.54 | 427,668 (Direct) | View |
| 2020-11-09 Exercise | 2020-11-12 5:49 pm | 2014-03-01 2024-02-06 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 43,505 | $0 | 427,668 (Direct) | View |
| 2020-10-20 Exercise | 2020-10-22 6:02 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 29,166 | $6.15 | 471,173 (Direct) | View |
| 2020-10-20 Exercise | 2020-10-22 6:02 pm | 2016-02-01 2026-01-01 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer | 29,166 | $0 | 471,173 (Direct) | View |